CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $20,577,126
- in 17 filings, $20.2M under 10b5-1 plans
Net −$20,577,126. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
- Quinlan Paul T −$1.7M General Counsel sold 40% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-01 | Fairmount Funds Management LLC Director | Conversion | +3,553,410 | 4,685,364 | ||
| 2026-07-01 | Fairmount Funds Management LLC Director | Sale | −3,553,410 | $84.43 | $300.0M | 1,131,954 |
| 2026-07-01 | Fairmount Funds Management LLC Director | Conversion · Series B Preferred Stock | −42,641 | 94,497 | ||
| 2026-06-02 | Fairmount Funds Management LLC Director | Grant or award · Stock Option (Right to Buy) | +9,136 | 9,136 | ||
| 2025-09-17 | Fairmount Funds Management LLC Director | Grant or award | +333,340 | $15.00 | $5.0M | 1,131,954 |
| 2025-06-02 | Fairmount Funds Management LLC Director | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2024-11-19 | Fairmount Funds Management LLC Director | Option exercise | +160,000 | 798,614 | ||
| 2024-11-19 | Fairmount Funds Management LLC Director | Option exercise · Series A Non-Voting Convertible Preferred Stock | −160 | 0 | ||
| 2024-09-11 | Fairmount Funds Management LLC Director | Grant or award | +275,000 | $23.00 | $6.3M | 638,614 |
| 2024-09-11 | Fairmount Funds Management LLC Director | Grant or award · Series A Non-Voting Convertible Preferred Stock | +160 | $23,000.00 | $3.7M | 160 |
Page 1 of 1 · 10 trades